Biocomposite macroporous cryogels as potential carrier scaffolds for bone active agents augmenting bone regeneration

J Control Release. 2016 Aug 10:235:365-378. doi: 10.1016/j.jconrel.2016.05.061. Epub 2016 May 29.

Abstract

Osteoinduction can be enhanced by combining scaffolds with bone morphogenic protein-2 (BMP-2). However, BMP's are known to also cause bone resorption. This can be controlled using bisphosphonates like zoledronic acid (ZA). In this study, we produced two different scaffolds containing silk-fibroin, chitosan, agarose and hydroxyapatite (HA) with and without bioactive glass. The aims of the study were to fabricate, physico-chemically characterize and evaluate the carrier properties of the scaffolds for recombinant human BMP-2 (rhBMP-2) and ZA. Scaffolds were characterized using various methods to confirm their composition. During cell-material interactions, both scaffolds exhibited gradual but sustained proliferation of both C2C12 and MSCs for a period of 6weeks with augmentative effects on their phenotype indicated by elevated levels of alkaline phosphatase (ALP) cuing towards osteogenic differentiation. In-vitro effects of rhBMP-2 and ZA contained within both the scaffolds was assessed on MC3T3 preosteoblast cells and the results show a significant increase in the ALP activity of the cells seeded on scaffolds with rhBMP-2. Further, the scaffold with both HA and bioactive glass was considered for the animal study. In-vitro, this scaffold released nearly 25% rhBMP-2 in 21-days and the addition of ZA did not affect the release. In the animal study, the scaffolds were combined with rhBMP-2 and ZA, rhBMP-2 or implanted alone in an ectopic muscle pouch model. Significantly higher bone formation was observed in the scaffold loaded with both rhBMP-2 and ZA as seen from micro-computed tomography, histomorphometry and energy dispersive X-ray spectroscopy.

Keywords: Biocomposite; Biomaterial; Bone tissue engineering; Cryogel; Zoledronic acid.

MeSH terms

  • Alkaline Phosphatase / metabolism
  • Animals
  • Bone Morphogenetic Protein 2 / administration & dosage*
  • Bone Morphogenetic Protein 2 / chemistry
  • Bone Regeneration
  • Cell Line
  • Cell Proliferation / drug effects
  • Chitosan / chemistry
  • Cryogels / administration & dosage*
  • Cryogels / chemistry
  • Diphosphonates / administration & dosage*
  • Diphosphonates / chemistry
  • Drug Carriers / administration & dosage*
  • Drug Carriers / chemistry
  • Durapatite / chemistry
  • Fibroins / chemistry
  • Glass / chemistry
  • Imidazoles / administration & dosage*
  • Imidazoles / chemistry
  • Male
  • Mice
  • Osteogenesis / drug effects
  • Porosity
  • Rats, Sprague-Dawley
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / chemistry
  • Sepharose / chemistry
  • Zoledronic Acid

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Cryogels
  • Diphosphonates
  • Drug Carriers
  • Imidazoles
  • Recombinant Proteins
  • Zoledronic Acid
  • Fibroins
  • Sepharose
  • Chitosan
  • Durapatite
  • Alkaline Phosphatase